Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OFA-VATS: Opioid-free anesthesia vs opioid-based anesthesia in video or robot-assisted thoracic surgery
2025-524240-35-00Phase 4Authorised
- Sponsor
- CHU Rennes
- Start
- Jun 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, sufentanil and remifentanil in Chest diseases (2 arms), sponsored by CHU Rennes. Primary endpoint: QoR-15 score on postoperative day 1. Planned start Jun 2026; status: authorised.
02
Drugs
dexmedetomidinesufentanilremifentanil
03
Conditions
Chest diseases
Beyond the preview
Go deeper on 2025-524240-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524240-35-00.